|
1
|
Lichtenberger BM, Tan PK, Niederleithner
H, Ferrara N, Petzelbauer P and Sibilia M: Autocrine VEGF signaling
synergizes with EGFR in tumor cells to promote epithelial cancer
development. Cell. 140:268–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ribatti D, Nico B, Crivellato E, Roccaro
AM and Vacca A: The history of the angiogenic switch concept.
Leukemia. 21:44–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roskoski R Jr: Vascular endothelial growth
factor (VEGF) signaling in tumor progression. Crit Rev Oncol
Hematol. 62:179–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferrara N and Davis-Smyth T: The biology
of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
MacGabhann F and Popel AS: Systems biology
of vascular endothelial growth factors. Microcirculation.
15:715–738. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vempati P, Popel AS and Mac GF:
Extracellular regulation of VEGF: Isoforms, proteolysis and
vascular patterning. Cytokine Growth Factor Rev. 25:1–19. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Otrock ZK, Makarem JA and Shamseddine AI:
Vascular endothelial growth factor family of ligands and receptors:
Review. Blood Cells Mol Dis. 38:258–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knizetova P, Ehrmann J, Hlobilkova A,
Vancova I, Kalita O, Kolar Z and Bartek J: Autocrine regulation of
glioblastoma cell-cycle progression, viability and radioresistance
through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle. 7:2553–2561.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chakraborty G, Jain S and Kundu GC:
Osteopontin promotes vascular endothelial growth factor-dependent
breast tumor growth and angiogenesis via autocrine and paracrine
mechanisms. Cancer Res. 68:152–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hamerlik P, Lathia JD, Rasmussen R, Wu Q,
Bartkova J, Lee M, Moudry P, Bartek J Jr, Fischer W, Lukas J, et
al: Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma
stem-like cell viability and tumor growth. J Exp Med. 209:507–520.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vannucci L, Lai M, Chiuppesi F,
Ceccherini-Nelli L and Pistello M: Viral vectors: A look back and
ahead on gene transfer technology. New Microbiol. 36:1–22.
2013.PubMed/NCBI
|
|
15
|
Nathwani AC, Tuddenham EGD, Rangarajan S,
Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ,
Harrington C, et al: Adenovirus-associated virus vector-mediated
gene transfer in hemophilia b. N Engl J Med. 365:2357–2365. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giacca M and Zacchigna S: Virus-mediated
gene delivery for human gene therapy. J Control Release.
161:377–388. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang S and Kamihira M: Development of
hybrid viral vectors for gene therapy. Biotechnol Adv. 31:208–223.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lehto T, Simonson OE, Mager I, Ezzat K,
Sork H, Copolovici D, Viola JR, Zaghloul EM, Lundin P, Moreno PM,
et al: A peptide-based vector for efficient gene transfer in vitro
and in vivo. Mol Ther. 19:1457–1467. 2011. View Article : Google Scholar
|
|
19
|
Mingozzi F and High KA: Therapeutic in
vivo gene transfer for genetic disease using AAV: Progress and
challenges. Nat Rev Genet. 12:341–355. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heilbronn R and Weger S: Viral vectors for
gene transfer: Current status of gene therapeutics. Handb Exp
Pharmacol. 143–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang S, Zeng X, Liu Y, Liang C, Zhang H,
Liu C, Du W and Zhang Z: Construction and characterization of a
PDCD5 recombinant lentivirus vector and its expression in tumor
cells. Oncol Rep. 28:91–98. 2012.PubMed/NCBI
|
|
22
|
Robinson CJ and Stringer SE: The splice
variants of vascular endothelial growth factor (VEGF) and their
receptors. J Cell Sci. 114:853–865. 2001.PubMed/NCBI
|
|
23
|
Ghosh S, Sullivan CA, Zerkowski MP,
Molinaro AM, Rimm DL, Camp RL and Chung GG: High levels of vascular
endothelial growth factor and its receptors (VEGFR-1, VEGFR-2,
neuropilin-1) are associated with worse outcome in breast cancer.
Hum Pathol. 39:1835–1843. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshiji H, Gomez DE, Shibuya M and
Thorgeirsson UP: Expression of vascular endothelial growth factor,
its receptor, and other angiogenic factors in human breast cancer.
Cancer Res. 56:2013–2016. 1996.PubMed/NCBI
|
|
25
|
Goel HL and Mercurio AM: VEGF targets the
tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guzmán-Hernández ML, Potter G, Egervári K,
Kiss JZ and Balla T: Secretion of VEGF-165 has unique
characteristics, including shedding from the plasma membrane. Mol
Biol Cell. 25:1061–1072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kotterman MA and Schaffer DV: Engineering
adeno-associated viruses for clinical gene therapy. Nat Rev Genet.
15:445–451. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mahn M, Ron S and Yizhar O: Viral
vector-based techniques for optogenetic modulation in vivoViral
Vector Approaches in Neurobiology and Brain Diseases. Brambilla R:
Humana Press; Totowa, NJ: pp. 289–310. 2014, View Article : Google Scholar
|
|
29
|
Barrett DM, Singh N, Porter DL, Grupp SA
and June CH: Chimeric antigen receptor therapy for cancer. Annu Rev
Med. 65:333–347. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miller AD and Rosman GJ: Improved
retroviral vectors for gene transfer and expression. Biotechniques.
7:980–990. 1989.PubMed/NCBI
|
|
31
|
Maetzig T, Galla M, Baum C and Schambach
A: Gammaretroviral vectors: Biology, technology and application.
Viruses. 3:677–713. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Burns JC, Friedmann T, Driever W,
Burrascano M and Yee JK: Vesicular stomatitis virus G glycoprotein
pseudotyped retroviral vectors: concentration to very high titer
and efficient gene transfer into mammalian and nonmammalian cells.
Proc Natl Acad Sci U S A. 90:8033–8037. 1993. View Article : Google Scholar : PubMed/NCBI
|
